中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

HBV相关肾小球肾炎的研究进展

安爽 张睿 杨文轩 周鸿捷 张泽天 杨以良 郭晓林

安爽, 张睿, 杨文轩, 周鸿捷, 张泽天, 杨以良, 郭晓林. HBV相关肾小球肾炎的研究进展[J]. 临床肝胆病杂志, 2016, 32(2): 366-369. DOI: 10.3969/j.issn.1001-5256.2016.02.037
引用本文: 安爽, 张睿, 杨文轩, 周鸿捷, 张泽天, 杨以良, 郭晓林. HBV相关肾小球肾炎的研究进展[J]. 临床肝胆病杂志, 2016, 32(2): 366-369. DOI: 10.3969/j.issn.1001-5256.2016.02.037
An Shuang, Zhang Rui, Yang WenXuan, Zhou HongJie, Zhang ZeTian, Yang YiLiang, Guo XiaoLin. Research advances in hepatitis B virus-associated glomerulonephritis[J]. J Clin Hepatol, 2016, 32(2): 366-369. DOI: 10.3969/j.issn.1001-5256.2016.02.037
Citation: An Shuang, Zhang Rui, Yang WenXuan, Zhou HongJie, Zhang ZeTian, Yang YiLiang, Guo XiaoLin. Research advances in hepatitis B virus-associated glomerulonephritis[J]. J Clin Hepatol, 2016, 32(2): 366-369. DOI: 10.3969/j.issn.1001-5256.2016.02.037

HBV相关肾小球肾炎的研究进展

DOI: 10.3969/j.issn.1001-5256.2016.02.037
详细信息
  • 中图分类号: R512.62;R692.31

Research advances in hepatitis B virus-associated glomerulonephritis

  • 摘要: HBV相关肾小球肾炎(HBV-GN)是慢性HBV感染最常见的肝外损伤之一,近年来受到众多学者重视。阐述了HBV-GN相关危险因素、发病机制、病理特点及治疗等方面取得的进展。目前HBV-GN诊断率低、样本量少,认为该病具有较大的研究空间,未来需要更多、更优质的临床试验去探索解决方案。

     

  • [1]COMBES B,SHOREY J,BARRERA A,et al.Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane[J].Lancet,1971,2(7718):234-237.
    [2] Editorial Board of Chinese Journal of Internal Medicine.Minutes of the symposium on hepatitis B virus-associated glomerulonephritis[J].Chin J Intern Med,1990,29(9):519-521.(in Chinese)中华内科杂志编委会.乙型肝炎病毒相关性肾炎座谈会纪要[J].中华内科杂志,1990,29(9):519-521.
    [3] BHIMMA R,COOVADIA HM.Hepatitis B virus-associated nephropathy[J].Am J Nephrol,2004,24(2):198-211.
    [4]SHIMIZU I,KOHNO N,TAMAKI K,et al.Female hepatology:favorable role of estrogen in chronic liver disease with hepatitis B virus infection[J].World J Gastroenterol,2007,13(32):4295-4305.
    [5]GILBERT RD,WIGGELINKHUIZEN J.The clinical course of hepatitis B virus-associated nephropathy[J].Pediatr Nephrol,1994,8(1):11-14.
    [6]LAI KN,LAI FM,TAM JS.Comparison of poly-clonal and monoclonal antibodies in determi-nation of glomerular deposits of hepatitis B virus antigens in hepatitis B virus-associated glomerulonephritis[J].Am J Clin Pathol,1989,92(2):159-165.
    [7]LIN CY,LIN CC,CHANG GJ,et al.Defect of cell-mediated immune response against hepatitis B virus:an indication of pathogenesis of hepatitis B virus-associated membranous nephropathy[J].Nephron,1997,76(2):176-185.
    [8]HE XY,FANG LJ,ZHANG YE,et al.In situ hybridisation of hepatitis B DNA in hepatitis B-associated glomerulonephritis[J].Pediatr Nephrol,1998,12(2):117-120.
    [9]LAI KN,LAI FM.Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults[J].Kidney Int Suppl,1991,35:s40-s45.
    [10]TAKEKOSHI Y,TOCHIMARU H,NAGATA Y,et al.Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy[J].Kidney Int Suppl,1991,35:s34-s49.
    [11]LAI KN,LI PK,LUI SF,et al.Membranous nephropathy related to hepatitis B virus in adults[J].N Engl J Med,1991,324(21):1457-1463.
    [12]BHIMMA R,COOVADIA HM.Hepatitis B virus-associated nephropathy[J].Am J Nephrol,2004,24(2):198-211.
    [13]LU P,YU YH,ZHUANG YZ,et al.Clinicopathological analysis of hepatitis B virus-associated glomerulonephritis[J].Chin J Integr Tradit West Nephrol,2011,12(6):541-543.(in Chinese)卢萍,余英豪,庄永泽,等.乙型肝炎病毒相关性肾炎临床病理分析[J].中国中西医结合肾病杂志,2011,12(6):541-543.
    [14]WANG NS.Research advances in hepatitis B virus-associated glomerulonephritis[C]∥Compilation of plenary lectures at The Fourth International Nephrology Conference of Integrated Traditional Chinese and Western Medicine.Tianjin:Nephrology Committee,China Society of Integrated Traditional Chinese and Western Medicine,2006:94-100.(in Chinese)汪年松.乙型肝炎病毒相关性肾炎的研究进展[C]∥第四届国际中西医结合肾脏病学术会议专题讲座汇编.天津:中国中西医结合学会肾病专业委员会,2006:94-100.
    [15]LEI QY,ZHAO JH,TANG JY.Effects of hemodialysis on immune function of patients with end-stage nephropathy associated HBV virus infection[J].Chin J Immunol,2014,30(12):1679-1682.(in Chinese)雷湫宇,赵景宏,唐建英.血液透析对终末期肾病合并HBV病毒感染患者免疫功能的影响[J].中国免疫学杂志,2014,30(12):1679-1682.
    [16]LIN CY.Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon[J].Kidney Int,1995,47(1):225-230.
    [17]BHIMMA R,COOVADIA HM,KRAMVIS A,et al.Treatment of hepatitis B virus-associated nephropathy in blank children[J].Pediatr Nephrol,2002,17(6):393-399.
    [18]CONJEEVARAM HS,HOOFNAGLE JH,AUSTIN HA,et al.Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa[J].Gastroenterology,1995,109(2):540-546.
    [19]CHUNG DR,YANG WS,KIM SB,et al.Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon[J].Am J Nephrol,1997,17(2):112-117.
    [20]KHEDMAT H,TAHERI S.Hepatitis B virus-associated nephropathy:an international data analysis[J].Iran J Kidney Dis,2010,4(2):101-105.
    [21]YI Z,JIE YW,NAN Z.The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis:a systematic review and meta-analysis[J].Ann Hepatol,2011,10(2):165-173.
    [22] ZHENG XY,WEI RB,TANG L,et al.Meta-analysis of combined therapy for adult hepatitis B virus-associated glo-merulonephritis[J].World J Gastroenterol,2012,18(8):821-832.
    [23]YANG YF,XIONG QF,ZHAO W,et al.Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy[J].Clin Res Hepatol Gastroenterol,2012,36(5):e89-e92.
    [24]DAS P,VIVEK V,FORD M,et al.Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir[J].BMJ Case Rep,2011,2011.pii:bcr0520114287.
    [25]LAI KN,TAM JS,LIN HJ,et al.The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia[J].Nephron,1990,54(1):12-17.
    [26]SAYARLIOGLU H,ERKOC R,DOGAN E,et al.Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication[J].Ann Pharmacother,2005,39(3):573.
    [27]SHIN SK,RYU DR,HWANG JH,et al.Comparison between lamivudine alone and lamivudine and steroid combination in treatment of nephrotic syndrome associated with hepatitis B[J].Korean J Nephrol,1999,18(4):550-559.
    [28]ZHENG XY,WEI RB,TANG L,et al.Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis[J].World J Gastroenterol,2012,18(8):821-832.
    [29]MITKA M.FDA:Increased HBV reactivation risk with ofatumumab or rituximab[J].JAMA,2013,310(16):1664.
    [30]GUILLEVIN L,MAHR A,CALLARD P,et al.Hepatitis B virus-associated polyarteritis nodosa:clinical characteristics,outcome,and impact of treatment in 115 patients[J].Medicine(Baltimore),2005,84(5):313-322.
    [31]LUO D.Treatment of HBV-GN with mycophenolate combined with lamivudine:report of 30 cases[J].J Navy Medicine,2009,30(2):114-116.(in Chinese)骆丹.霉酚酸酯联合拉米呋啶治疗乙肝病毒相关性肾炎30例临床分析[J].海军医学杂志,2009,30(2):114-116.
    [32]XIANG H,SUN J.Comparison between lenfluomide and mycophenolate mofeil treatment in HBV-associated glomerulonephritis[J].Clin Med Eng,2011,18(2):213-215.(in Chinese)向慧,孙剑.来氟米特与霉酚酸酯治疗乙肝病毒相关性肾炎的疗效比较[J].临床医学工程,2011,18(2):213-215.
    [33]CHEN JL.Treatment in Hepatitis B virus-associated nephritis[J].J Continuing Med Education,2006,20(7):33-36.(in Chinese)陈京龙.乙型肝炎病毒相关性肾炎的治疗[J].继续医学教育,2006,20(7):33-36.
  • 加载中
计量
  • 文章访问数:  1250
  • HTML全文浏览量:  16
  • PDF下载量:  440
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-07-29
  • 出版日期:  2016-02-20
  • 刊出日期:  2016-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回